Please find enclosed herewith the details of shares dematerialised during April 2026 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018

PANACEABIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-2.5%1-day move

₹400.00

prior close

₹403.60

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.1-0.1-0.2+0.1-2.5-4.3-8.2-2.8-4.5+1.3+2.8+38.3+34.0—

Up moveDown movePending

AI summary

Panacea Biotec has filed its monthly dematerialization status report for April 2026 as required under SEBI regulations. The company confirms that no new shares were dematerialized during April 2026. However, the RTA report shows an inter-depository movement where 92,865 shares were transferred from CDSL to NSDL during the month. Total dematerialized shares as of April 30, 2026 stand at 6,11,04,526 (approximately 61.1 crore shares), comprising 5,36,44,500 in NSDL and 74,60,026 in CDSL. The filing includes a certificate from the company's RTA, Skyline Financial Services Pvt. Ltd.

Likely market impact

This is a routine regulatory compliance filing with no direct impact on shareholders or stock price. The inter-depository transfer reflects routine operational activity with no change in total dematerialized share count.